Establishing the Obesity Paradox in Alpha-1 Antitrypsin Deficiency-Related COPD
Authors:
- Daniel YeeDYDaniel Yee
- Monica P. GoldklangMGMonica P. Goldklang
Open Access
- 8 February 2025
- journal article
- Published by Elsevier in CHEST Pulmonary
- Vol. 3 (2)
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Longitudinal Evaluation of Individuals With Severe Alpha-1 Antitrypsin Deficiency (Pi∗ZZ Genotype)Gastroenterology, 2024
- Mortality and Exacerbation Risk by Body Mass Index in Patients with COPD in TIOSPIR and UPLIFTAnnals of the American Thoracic Society, 2022
- Challenging the obesity paradox: extreme obesity and COPD mortality in the SUMMIT trialERJ Open Research, 2021
- Obesity and Severity of Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseAnnals of the American Thoracic Society, 2018
- Chest computed tomography-derived low fat-free mass index and mortality in COPDEuropean Respiratory Journal, 2017
- Obesity Is Associated With Increased Morbidity in Moderate to Severe COPDChest, 2017
- A Review of α1-Antitrypsin DeficiencyAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Body mass index and mortality in patients with severe α1-antitrypsin deficiencyRespiratory Medicine, 1997
- Airways obstruction and two year survival in patients with severe alpha 1-antitrypsin deficiencyEuropean Respiratory Journal, 1994